The country is also advancing the integration of TCM into modern healthcare by optimizing its clinical use and expanding ...

China's commitment to foster innovation and advance high-standard opening-up has provided global pharmaceutical companies ...

The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to discover and develop next-generation multi-specific antibodies for ...

J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years.

Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...

AstraZeneca (AZN) stock in focus as the company invests $2.5B in Beijing for a new R&D center, strengthening its footprint in ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

LONDON (Reuters) - AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the ...

Fired workers and their States are suing Trump for unlawful dismissals. Meanwhile, the public is hitting Musk where it hurts most. Tesla stocks lost 50% of their value; no one wants to buy them or can ...

These attitudes are time and again reflected in Dutton’s commentaries and policies, particularly directed towards certain ...

America's pharmaceutical giants have been plotting to torpedo Australia's Pharmaceuticals Benefits Scheme, despite securing ...

According to the Dutch regulatory authority, the CMA could help reduce vulnerabilities in supply chains and improve the ...